[Chronic myeloid leukemia (CML): a therapeutic dilemma]

Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/ autotransplantation and who were conventionally treated.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1996

Chronic myeloid leukemia of thrombocythemic onset: a CML subtype with distinct hematological and molecular features?

Leukemia·1996

[Occult involvement of bone marrow in Hodgkin's disease: detection with magnetic resonance].

Medicina clinica·1996

[Treatment with fludarabine of lymphoid neoplasms with low grade malignity resistant to treatment or in relapse].

Medicina clinica·1996

Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients.

Annals of hematology·1996

Ovarian dermoid cyst-associated autoimmune hemolytic anemia: a case report with emphasis on pathogenic mechanisms.

American journal of clinical pathology·1996

Optimising the duration of antimicrobial treatment in the era of Antimicrobial Stewardship Programs.

Medicina clinica·2026

Reduced serum IL-6 as a potential peripheral marker of amnestic mild cognitive impairment: A pilot study.

Medicina clinica·2026

Foundations for the rational prescription of enteral medical nutrition therapy.

Medicina clinica·2026

Ambient AI scribe in pediatric outpatient visits: documentation burden, quality, and scale-up limits.

Medicina clinica·2026

Eating disorders.

Medicina clinica·2026

Tobacco-related and tobacco-attributable cancer mortality in Spain, 1999-2023: trends and gender inequalities.

Medicina clinica·2026

Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.

British journal of haematology·2026

Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

British journal of haematology·2026

Cytodiagnostic features of angiofibroma of soft tissue: A review of 16 cases to identify characteristic findings and their diagnostic significance.

Cancer cytopathology·2026

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.

Haematologica·2026

Prognostic relevance of RUNX1 mutations at acute myeloid leukemia diagnosis and as measurable residual disease marker before and after allogeneic stem cell transplantation.

Haematologica·2026

KSR2 is a novel oncogene in TAL1 subtype of T-cell acute lymphoblastic leukemia with potential clinical and prognostic implications.

Haematologica·2026

Related Experiment Videos

[Chronic myeloid leukemia (CML): a therapeutic dilemma]

Related Concept Videos

Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/ autotransplantation and who were conventionally treated.

Chronic myeloid leukemia of thrombocythemic onset: a CML subtype with distinct hematological and molecular features?

[Occult involvement of bone marrow in Hodgkin's disease: detection with magnetic resonance].

[Treatment with fludarabine of lymphoid neoplasms with low grade malignity resistant to treatment or in relapse].

Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients.

Ovarian dermoid cyst-associated autoimmune hemolytic anemia: a case report with emphasis on pathogenic mechanisms.

Optimising the duration of antimicrobial treatment in the era of Antimicrobial Stewardship Programs.

Reduced serum IL-6 as a potential peripheral marker of amnestic mild cognitive impairment: A pilot study.

Foundations for the rational prescription of enteral medical nutrition therapy.

Ambient AI scribe in pediatric outpatient visits: documentation burden, quality, and scale-up limits.

Eating disorders.

Tobacco-related and tobacco-attributable cancer mortality in Spain, 1999-2023: trends and gender inequalities.

Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.

Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

Cytodiagnostic features of angiofibroma of soft tissue: A review of 16 cases to identify characteristic findings and their diagnostic significance.

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.

Prognostic relevance of RUNX1 mutations at acute myeloid leukemia diagnosis and as measurable residual disease marker before and after allogeneic stem cell transplantation.

KSR2 is a novel oncogene in TAL1 subtype of T-cell acute lymphoblastic leukemia with potential clinical and prognostic implications.

Related Experiment Videos

[Chronic myeloid leukemia (CML): a therapeutic dilemma]

Related Concept Videos

Related Articles